DIANPH, diabetic nephropathy, 23771

N. diseases: 35; N. variants: 0
Disease: Kidney Failure, Chronic ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0022661
Disease: Kidney Failure, Chronic
Kidney Failure, Chronic 		0.100 GeneticVariation disease BEFREE Diabetic nephropathy (dNP), a leading cause of end-stage renal disease in industrialized countries, is mechanistically closely linked with ER stress and renal cell death. 31701452 2020
CUI: C0022661
Disease: Kidney Failure, Chronic
Kidney Failure, Chronic 		0.100 GeneticVariation disease BEFREE Diabetic Nephropathy (DN) is the most common cause of end-stage renal disease associated with high mortality worldwide. 31188032 2019
CUI: C0022661
Disease: Kidney Failure, Chronic
Kidney Failure, Chronic 		0.100 Biomarker disease BEFREE Diabetic nephropathy (DN) is the leading cause of end-stage renal disease worldwide with high morbidity and mortality. 31410160 2019
CUI: C0022661
Disease: Kidney Failure, Chronic
Kidney Failure, Chronic 		0.100 Biomarker disease BEFREE Diabetic nephropathy (DN) affects about 40% of diabetes mellitus (DM) patients and is the leading cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) all over the world, especially in high- and middle-income countries. 31409386 2019
CUI: C0022661
Disease: Kidney Failure, Chronic
Kidney Failure, Chronic 		0.100 Biomarker disease BEFREE Diabetic nephropathy (DN) is a major microvascular complication that develops in nearly 20-30% of patients with type 2 diabetes (T2D) and is currently the leading cause of end stage renal disease (ESRD). 25154422 2015
CUI: C0022661
Disease: Kidney Failure, Chronic
Kidney Failure, Chronic 		0.100 Biomarker disease BEFREE Diabetic nephropathy (DN) is the most common cause of end-stage renal disease and identification of new therapeutic targets is needed. 24287278 2014
CUI: C0022661
Disease: Kidney Failure, Chronic
Kidney Failure, Chronic 		0.100 Biomarker disease BEFREE Diabetic nephropathy (DN) is a major cause of end stage kidney disease and a strong risk factor for cardiovascular diseases. 24361893 2014
CUI: C0022661
Disease: Kidney Failure, Chronic
Kidney Failure, Chronic 		0.100 Biomarker disease BEFREE Diabetic nephropathy is the leading cause of end-stage renal disease in the most developed countries of the world. 23831394 2013
CUI: C0022661
Disease: Kidney Failure, Chronic
Kidney Failure, Chronic 		0.100 Biomarker disease BEFREE Diabetic nephropathy (DN) was categorized by urinary albumin excretion (UAE) as normoalbuminuria (n=247), microalbuminuria (n=68), macroalbuminuria (n=70), or the presence of end-stage renal disease (dialysis; n=134). 20097100 2011
CUI: C0022661
Disease: Kidney Failure, Chronic
Kidney Failure, Chronic 		0.100 Biomarker disease BEFREE Diabetic nephropathy is the most common cause of end-stage renal disease in the Western world. 19546580 2009
CUI: C0022661
Disease: Kidney Failure, Chronic
Kidney Failure, Chronic 		0.100 Biomarker disease BEFREE Diabetic nephropathy (DN) is the leading cause of end-stage renal disease. 16813599 2006
CUI: C0022661
Disease: Kidney Failure, Chronic
Kidney Failure, Chronic 		0.100 Biomarker disease BEFREE Diabetic nephropathy is associated with progressive renal damage, leading to impaired function and end-stage renal failure. 17170520 2006
CUI: C0022661
Disease: Kidney Failure, Chronic
Kidney Failure, Chronic 		0.100 Biomarker disease BEFREE Diabetic nephropathy is the most common cause of end-stage renal disease (ESRD) in Japan, Western Europe, and the United States. 16174283 2005